BIRC5 and cancer: It still remains unclear whether alternative splicing of Survivin is an adaptation used by cancer cells to support their proliferation and avoid detection by immune surveillance Association of splice variants with distinct pathological and survival outcomes indicate possible role of these variants in disease progression.